Clinical trial researches focal therapy for prostate cancer

Female doctor with male patient

Image credit: Canva

Prostate cancer is typically slow-growing, with some tumors being small, low-grade and noninvasive. Researchers want to know if focal ablation could be an effective therapy method with minimal side effects. A clinical trial led by Peter A. Pinto, M.D., Senior Investigator in the Urologic Oncology Branch, is researching MRI-guided ultrasound-induced thermal therapy for prostate cancer.

The trial will take place at the NIH Clinical Center in Bethesda, Maryland, and there is no cost for participation.

For more information, contact Jill Harper at (240) 974-5755 or identifier: NCT04808427

NCI Protocol ID: 21-C-0017

Official Title: Magnetic Resonance Image (MRI) Guided High Energy Ultrasound for Focal Prostate Cancer Ablation

The Center for Cancer Research is NCI’s internal cancer center, a publicly funded organization working to improve the lives of cancer patients by solving important, challenging and neglected problems in cancer research and patient care. Highly trained physician-scientists develop and carry out clinical trials to create the medicines of tomorrow treating patients at the world’s largest dedicated research hospital on the campus of the National Institutes of Health in Bethesda, Maryland.  

For more information on CCR clinical trials click here, and subscribe to have the latest CCR clinical trials sent directly to your inbox.

Posted on Tue, 09/26/2023